# Correction: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. Cancers 2022, 14, 326

**Authors:** Bin Lan, Siyuan Zeng, Shuman Zhang, Xiaofan Ren, Yuming Xing, Isabella Kutschick, Susanne Pfeffer, Benjamin Frey, Nathalie Britzen-Laurent, Robert Grützmann, Nils Cordes, Christian Pilarsky

PMC · DOI: 10.3390/cancers17193181 · Cancers · 2025-09-30

## Full-text entities

- **Genes:** DYRK1A (dual specificity tyrosine phosphorylation regulated kinase 1A) [NCBI Gene 1859] {aka DYRK, DYRK1, HP86, MNB, MNBH, MRD7}
- **Diseases:** Pancreatic Cancer (MESH:D010190)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12523602/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12523602/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12523602/full.md

---
Source: https://tomesphere.com/paper/PMC12523602